Novel valproic acid derivatives with hemoglobin F inducing activity

American Journal of Hematology

Volumn 81, Issue 5, 2006, Pages 374-376

  Ronndahl G ^a   Monkemeyer S ^a   Schulze, S ^a   Pekrun, A ^b   Eikel, D ^c   Nau, H ^c   Witt, O ^d,e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Prof Hess Children's Hospital   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HbF; Hemoglobin F; K562; Thalassemia; Valproate; Valproic acid; VPA

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F; VALPROIC ACID DERIVATIVE;

ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DRUG ACTIVITY; ERYTHROID CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; SICKLE CELL ANEMIA;

CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL HEMOGLOBIN; HUMANS; K562 CELLS; STRUCTURE-ACTIVITY RELATIONSHIP; VALPROIC ACID;

EID: 33646471844     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20575     Document Type: Article

References (9)

1. Olivieri NF, Weatherall DJ. The therapeutic reactivation of fetal haemoglobin. Hum Mol Genet 1998;7(10):1655-1658.
2. Liakopoulou E, Blau CA, Li Q, et al. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood 1995;86(8):3227-3235.
3. Collins AF, Dover GJ, Luban NL. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy. Blood 1994;84(5):1690-1691.
4. Kieslich M, Schwabe D, Cinatl J Jr, Driever PH. Increase of fetal hemoglobin synthesis indicating differentiation induction in children receiving valproic acid. Pediatr Hematol Oncol 2003;20(1):15-22.
5. Witt O, Mönkemeyer S, Rönndahl G, et al. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 2003;101(5):2001-2007.
6. Witt O, Mönkemeyer S, Kanbach K, Pekrun A. Induction of fetal hemoglobin synthesis by valproate: modulation of MAP kinase pathways. Am J Hematol 2002;71(1):45-46.
7. Bojic U, Elmazar MM, Hauck RS. Nau H. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect. Chem Res Toxicol 1996;9(5):866-870.
8. Bojic U, Ehlers K, Ellerbeck U, et al. Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre. Eur J Pharmacol 1998;354(2-3):289-299.
9. Gravemann U. Synthesis of achiral, racemic and enantiomerically pure Valproic acid derivatives with anticonvulsant, neurotoxic and teratogenic potency. Ph.D. thesis. Hannover, Germany: University of Veterinary Medicine Hannover; 2002.